Influence of renal failure in rats on the disposition of salicyl acyl glucuronide and covalent binding of salicylate to plasma proteins

Journal of Pharmacology and Experimental Therapeutics

Volumn 278, Issue 1, 1996, Pages 277-283

  Liu, Jian Hua ^a   Malone, Rebecca S ^b,c   Stallings, Hollie ^b   Smith, Philip C ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMA PROTEIN; SALICYL GLUCURONIDE; SALICYLIC ACID; SERUM ALBUMIN; URANYL NITRATE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; COVALENT BOND; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISPOSITION; DRUG HALF LIFE; DRUG HYDROLYSIS; DRUG PROTEIN BINDING; DRUG STABILITY; INTRAVENOUS DRUG ADMINISTRATION; ISOMERISM; KIDNEY CLEARANCE; KIDNEY FAILURE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BINDING, COMPETITIVE; BLOOD PROTEINS; GLUCURONATES; KIDNEY FAILURE; RATS; SALICYLATES; SALICYLIC ACIDS;

EID: 0030441129     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. ABDALLAH, H. Y., MAYERSON, M. AND CONTRAD, K. A.: The influence of age on salicylate pharmacokinetics in humans. J. Clin. Pharmacol. 31: 380-387, 1991.
2. ANTHONY, M. L., GARTLAND, K. P. R., BEDDELL, C. R., LINDON, J. C. AND NICHOLSON J. K.: Studies of the biochemical toxicology of uranyl nitrate. Arch. Toxicol. 88: 43-53, 1994.
3. BENET, L. Z., SPAHN-LANGGUTH, H., IWAKAWA, S., VOLLAND, C., MIZUMA, T., MAYER, S., MUTSCHLER, E. AND LIN, E. T.: Predictability of the covalent binding of acidic drugs in man. Life Sci. 53: 141-146, 1993.
4. BEKERSKY, I., FISHMAN, L., KAPLAN, S. A. AND COLBURN, W. A.: Renal clearance of salicylic acid and salicyluric acid in the rat and in the isolated perfused rat kidney. J. Pharmacol. Exp. Ther. 212: 309-314, 1980.
5. BEKERSKY, I. AND OLEJNIK, N.: Effect of probenecid on the renal tubular secretion of salicyluric acid by the isolated perfused rat kidney. Drug Metab. Dispos. 13: 630-633, 1985.
6. 9-11-carboxytetrahydrocannabinol glucuronide. Chem. Res. Toxicol. 2: 316-324, 1989.
7. BOWMER, C. J. AND LINDUP, W. E.: Decreased binding of drugs and dyes to plasma proteins from rats with acute renal failure: Effects of ureter ligation and intramuscular injection of glycerol. Br. J. Pharmacol. 66: 275-281, 1979.
8. COX, P. G. F., MOONS, W. M., RUSSEL, F. G. M. AND VAN GINNEKEN, C. A. M.: Renal handling and effects of salicylic acid in the isolated perfused rat kidney. Pharmacol. Toxicol. 69: 322-328, 1991.
9. DEAN, M., PENGLIS, S. AND STOCK, B.: The pharmacokinetics of salicylate in the pregnant Wistar rat. Drug Metab. Dispos. 17: 87-90, 1989.
10. DICKINSON, R. G., BAKER, P. V. AND KING, A. R.: Studies on the reactivity of acyl glucuronides. VII. Salicyl acyl glucuronide reactivity in vitro and covalent binding of salicylic acid to plasma protein of humans taking aspirin. Biochem. Pharmacol. 47: 469-476, 1994.
11. FAED, E. M.: Properties of acyl glucuronides: Implications for studies of the pharmacokinetics and metabolism of acidic drugs. Drug Metab. Rev. 15: 1213-1249, 1984.
12. GIACOMINI, K. M., ROBERTS, S. M. AND LEVY, G.: Evaluation of methods for producing renal dysfunction in rats. J. Pharmaceut. Sci. 70: 117-121, 1981.
13. GIBALDI, M. AND PERRIER, D. Pharmacokinetics, Marcel Dekker, New York, 1982.
14. HASEGAWA, J., SMITH, P. C. AND BENET, L. Z.: Apparent intramolecular acyl migration of zomepirac glucuronide. Drug Metab. Dispos. 10: 469-473, 1982.
15. HO, P. C., TRIGGS, E. J. AND BOURNE, W. A.: The effects of age and sex on the disposition of acetyl salicylic acid and its metabolites. Br. J. Pharmacol. 18: 675-684, 1985.
16. HYNECK, M. L., MUNAFO, A. AND BENET, L. Z.: Effect of pH on acyl migration and hydrolysis of tometin glucuronide. Drug Metab. Dispos. 16: 322-324, 1988.
17. IWAMOTO, K, TAKEI, M. AND WATANABE, J.: Gastrointestinal and hepatic firstpass metabolism of aspirin in rats. J. Pharm. Pharmacol. 34: 176-180, 1982.
18. LEVY, G.: Pharmacokinetics of salicylate in man. Drug Metab. Rev. 9: 3-19, 1979.
19. LIU, J. H. AND SMITH, P. C.: Direct analysis of salicylic acid, salicylate acyl glucuronide, salicyluric acid and gentisic acid in human plasma and urine by high performance liquid chromatography. J. Chromatogr. 675: 61-70, 1996.
20. LOWENTHAL, D. T., BRIGGS, W. A. AND LEVY, G.: Kinetics of salicylate elimination in anephric patients. J. Clin. Invest. 54: 1221-1226, 1974.
21. NEEDS, C. J. AND BROOKS, P. M.: Clinical pharmacokinetics of the salicylates. Clin. Pharmacokinetics 10: 164-177, 1985
22. NELSON, E., HANABU, M. AND LEVY, G.: Comparative pharmacokinetics of salicylate elimination in man and rats. J. Pharmacol. Exp. Ther. 153: 159-166, 1966.
23. PATEL., D. K., NOTARIANNI, L. J. AND BENNETT, P. N.: Comparative metabolism of high doses of aspirin in man and rat. Xenobiotica 20: 847-854, 1990.
24. ROTHKOPF-ISCHEBECK, M.: Differentiation of various experimentally-induced pathological processes in Wistar rats by serum protein electrophoresis using cellulose-acetate membranes. Lab. Animals 14: 153-165, 1980.
25. SCHACHTER, D.: The chemical estimation of acyl glucuronides and its application to studies on the metabolism of benzoate and salicylate in man. J. Clin. Invest. 36: 297-302, 1957.
26. SCHACHTER, D. AND MANIS, J. G.: Salicylate and salicyl conjugates: Fluorimetric estimation, biosynthesis and renal excretion in man. J. Clin. Invest. 37: 800-807, 1958.
27. SHETTY, B. V., BADR, M. AND MELETHIL, S.: Evaluation of hepatic metabolism of salicylic acid in perfused rat liver. J. Pharm. Sci. 83: 607-608, 1994.
28. SMITH, P. C., BENET, L. Z. AND MCDONAGH, A. F.: Covalent binding of zomepirac glucuronide to proteins: Evidence for a Schiff base mechanism. Drug Metab. Dispos. 18: 639-644, 1990.
29. SMITH, P. C., HASEGAWA, J., LANGENDIJK, P. N. J. AND BENET, L. Z.: Stability of acyl glucuronides in biological fluids: Studies with zomepirac. Drug Metab. Dispos. 13: 110-112, 1985.
30. SMITH, P. C. AND LIU, J. H.: Covalent binding of suprofen acyl glucuronide to albumin in vitro. Xenobiotica 23: 337-348, 1993.
31. SMITH, P. C. AND LIU, J. H.: Covalent binding of suprofen to renal tissue of rats correlates with excretion of its acyl glucuronide. Xenobiotica 25: 531-540, 1995.
32. SMITH, P. C., MCDONAGH, A. F. AND BENET, L. Z.: Irreversible binding of zomepirac to plasma protein in vitro and in vivo. J. Clin. Invest. 77: 934-939, 1986.
33. SPAHN-LANGGUTH, H. AND BENET, L. Z.: Acyl glucuronides revisited: Is the glucuronidation process a toxification as well as a detoxification mechanism? Drug Metab. Rev. 24: 5-48, 1992.
34. STEVENSON, D. D AND LEWIS, R. A.: Proposed mechanisms of aspirin sensitivity reactions. J. Aller. Clin. Immunol. 80: 788-790, 1987.
35. VAN BREEMAN, R. B. AND FENSELAU, C.: Acylation of albumin by 1-O-acyl glucuronides. Drug Metab. Dispos. 13: 318-320, 1985.
36. WAN, S. H. AND RIEGELMAN, S.: Renal contribution to overall metabolism of drugs. II. Biotranaformation of salicylic acid to salicyluric acid. J. Pharm. Sci. 61: 1284-1287, 1972.
37. WILLIAMS, A. M., WORRALL, S., JERSEY, J. D. AND DICKINSON, R. G.: Studies of the reactivity of acyl glucuronides. III. Glucuronide-derived adducts of valproic acid and plasma protein and anti-adduct antibodies in humans. Biochem. Pharmacol. 43: 745-755, 1992.
38. WORRALL, S. AND DICKINSON, R. G.: Rat serum albumin modified by diflunisal acyl glucuronide is immunogenic in rats. Life Sci. 56: 1921-1930, 1995.
39. YACOBI, A. AND LEVY, G.: Intraindividual relationships between protein binding of drugs in normal human subjects, patients with impaired renal function, and rats. J. Pharmaceut. Sci. 66: 1285-1288, 1977.
40. YUE, T. L. AND VARMA, D. R.: Pharmacokinetics, metabolism and disposition of salicylate in protein deficient rats. Drug Metab. Dispos. 10: 147-152, 1982.
41. ZIA-AMIRHOSSEINI, P., HARRIS, R. Z., BRODSKY, F. M. AND BENET, L. Z.: Hypersensitivity to nonsteroidal anti-inflammatory drugs. Natl. Med. 1: 2-4, 1995.
42. ZIA-AMIHHOSSEINI, P., OJINGWA, J. C., SPAHN-LANGGUTH, H., MCDONAGH, A. F. AND BENET, L. Z.: Enhanced covalent binding of tolmetin to proteins in humans after multiple dosing. Clin. Pharmacol. Ther. 55: 21-27, 1994.